Woodline Partners LP - 30 Sep 2025 SCHEDULE 13G Report for SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS)

Filing Manager: Woodline Partners LP
Reporting Manager: Woodline Partners LP
Security: SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: SABS
Shares outstanding: 71,978,596 shares
Disclosed Ownership: 7,125,881 shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Filing time: 14 Nov 2025, 16:18:27 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Woodline Partners LP	9.9%	7,125,881	7,125,881	0	/s/ Erin Mullen	Erin Mullen, General Counsel & Chief Compliance Officer